http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100126465-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b735f147a8c094f1c87c78a18cd69428 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
| filingDate | 2009-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30f2b899b706a79c4c666c3c7c202326 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e62ba05783e2c07fb1a7f707ed18187 |
| publicationDate | 2010-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20100126465-A |
| titleOfInvention | Modified Release Pharmaceutical Compositions Comprising Mycophenolate and Methods Thereof |
| abstract | Provided is a modified release pharmaceutical composition comprising mycophenolate or a pharmaceutically acceptable salt thereof, ester, polymorph, isomer, prodrug, solvate, hydrate, or derivative thereof as an active agent, the composition being in vitro It shows a biphasic release profile upon dissolution and / or in vivo administration. The composition provides drug release in a manner that is maintained above the therapeutically effective concentration (EC) continuously for an extended period of time. In addition, the difference between the maximum plasma concentration (C max ) of the drug and the minimum plasma concentration (C min ) of the drug, and in turn the flux defined as ((C max -C min ) / C avg ) is minimal. The invention also provides methods of making such dosage form compositions and methods of prophylaxis and / or treatment using such compositions. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220137785-A |
| priorityDate | 2008-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 139.